Bollard Group’s DexCom DXCM Stock Holding History

Bollard Group’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7K	Buy	+100	New	+$6.66K	﹤0.01%	273
2023 Q3	–	Sell	-20	Closed	-$3K	–	462
2023 Q2	$3K	Buy	+20	New	+$2.42K	﹤0.01%	466
2020 Q4	–	Sell	-1,600	Closed	-$165K	–	431
2020 Q3	$165K	Hold	1,600	–	–	0.01%	205
2020 Q2	$162K	Buy	1,600 +800	+100%	+$71.6K	0.01%	199
2020 Q1	$54K	Buy	+800	New	+$49.8K	﹤0.01%	173
2019 Q2	–	Sell	-800	Closed	-$24K	–	254
2019 Q1	$24K	Hold	800	–	–	﹤0.01%	226
2018 Q4	$24K	Buy	+800	New	+$25.4K	﹤0.01%	225

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bollard Group's DXCM Position: Q2 2026 in Review

Bollard Group opened a new position in DexCom (DXCM) in Q2 2026: 100 shares worth $7K. The stake represents ﹤0.01% of the portfolio and ranks #273 among its holdings. This is a return to the name: Bollard Group previously reported a position in DXCM as recently as Q2 2023.

Bollard Group first reported a position in DXCM in Q4 2018 and has held it in 7 quarters since. The position peaked at $165K in Q3 2020. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Bollard Group held 100 shares of DexCom worth $7K as of Q2 2026.
DexCom was a new Bollard Group position in Q2 2026.
DexCom made up ﹤0.01% of Bollard Group's portfolio in Q2 2026, its #273 holding.
Bollard Group first reported a position in DexCom in Q4 2018 and has held it in 7 quarters since.
Bollard Group's DexCom position peaked at $165K in Q3 2020.
974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Bollard Group's 13F filing for Q2 2026, filed 12 Aug 2026.